|
|
| Breast Cancer Information |
|
|
Screening For Breast Cancer With No Compression And No Radiation
Who would have thought that a technology for detecting breast cancer used today actually had its' roots dating back to 480 B.C.? Digital Infrared Thermal Imaging (DITI) is a fairly new technology that represents a practice that was once used by Hippocrates. This technology is based on a technique that Hippocrates would use as he spread mud over his patients and then watched to see which areas dried first. It was in those places on the body that could show a disease. It wasn't until 1957 that the first modern application of thermography came into existence when a Canadian doctor discovered that the skin temperature over a breast tumor was higher than that of healthy tissue. By 1982, the Food and Drug Administration approved thermography and classified it as an additional diagnostic tool for the detection of breast cancer. However, DITI was introduced as a diagnostic tool before strict protocols were established for both the technicians who performed the scans and the doctors who interpreted the scans. Shortly after its initial beginnings, DITI fell out of favor as a diagnostic tool in the medical community. There are now stringent protocols both for testing and interpreting. Perhaps due to these guidelines, thermography (as with all digital technology) has exploded in its technique and capabilities. Thermal cameras detect heat given off by the body and display it as a picture on a computer monitor. These images are unique to the person and they remain stable over time. It is because of these characteristics that thermal imaging is a valuable and effective screening tool to determine changes that could point to trouble down the road. As we all know, early cancer detection is important to survival. Another advantage is that, unlike mammography, there is no radiation and no compression of the breast; two significant reasons some women refuse mammography. Thermography measures temperature changes in the body. Tumors create their own blood vessels. Where there are more blood vessels, there is more heat. It is in these areas on the body that the camera detects changes in heat or temperature. Medical doctors who interpret the breast scans are board certified thermologists. Thermography can be utilized by women of all ages. It is not limited by breast density and is ideal for women who have had cosmetic or reconstructive surgery. Cancer typically has a 15 year life span from onset to death. Ideally, women should begin thermographic screenings by age 25. A woman diagnosed with breast cancer at age 40 possibly had the cancer as early as age 30. Since most women do not have a mammogram until age 40, there is a critical time period from age 25 to 39 that thermography could be extremely beneficial. Thermography does not replace mammography. However, it is an additional tool that is available to women. By combining both technologies, the detection rate increases to 95-98%, surpassing either technology as a stand-alone therapy. Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com. Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She is an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area.
MORE RESOURCES: Breastfeeding for at least six months might lower the risk of developing so-called "triple negative" breast cancer, an aggressive form of the disease that is more common in black and younger women, according to a study published on Monday in the journal Cancer, the Seattle Post-Intelligencer reports (Paulson, Seattle Post-Intelligencer, 8/24). A new promising enzyme target for a specific type of breast cancer, Brk, has been identified in research published on August 21, 2008 in the Proceedings of the National Academy of Sciences (PNAS.) In a specific subset of breast cancer patients, the tumor cells produce high levels of the protein ErbB2 (also called HER2) which pushes the cells to proliferate without limit, a characteristic common of all cancers. The American Medical Student Association (AMSA), the nation's oldest and largest, independent association for physicians-in-training, announces the commencement of AMSA Academy, a training ground for physician leaders. Established by students, for students, AMSA Academy takes medical students through the core competencies of leadership and project implementation, while building on key principles of important topics in medicine. There are currently 22 programs offered. Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease, according to a study by Professor Ronit Peled, at Ben-Gurion University of the Negev in Israel. An article on the study titled "Breast Cancer, Psychological Distress and Life Events among Young Women," was just published in the British journal BMC Cancer (8:245, August 2008). Feelings of happiness and optimism play a positive role against breast cancer. Research published in the open access journal BMC Cancer suggests that while staying positive has a protective role, adverse life events such as the loss of a parent or close relative, divorce or the loss of a spouse can increase a woman's risk of developing the disease. New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology. The findings suggest a cellular mechanism for the correlation between human breast tissue density and tumor aggressiveness. Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of these studies and highlights some of the questions that still need to be answered. A new study published on bmj.com argues that for older women, health related quality of life can be improved by hormone replacement therapy (HRT). The authors recommend that HRT guidelines should be revised with this most current evidence taken into consideration. Earlier studies have shown that HRT has the potential for general improvements in quality of life measures - how patients feel or function. Duke University chemists have patented an efficient technique for synthesizing a marine algae extract in sufficient quantities to now test its ability to inhibit the growth of cancerous cells while leaving normal cells unaffected. The researchers also deduced that this molecule -- called largazole -- acts on cells through the same chemical mechanism as other anti-cancer compounds on the market or in clinical trials. Seeking to improve on nature, scientists used a spice-based compound as a starting point and developed synthetic molecules that, in lab settings, are able to kill cancer cells and stop the cells from spreading. The researchers are combining organic chemistry, computer-aided design and molecular biology techniques in developing and testing pharmaceutical compounds that can fight breast and prostate cancer cells. ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the first patient has been treated in a global Phase 3 clinical trial of IMC-1121B, its anti-vascular endothelial growth factor receptor-2 (VEGFR-2) IgG1 monoclonal antibody, in women with metastatic breast cancer. Advocates, including those for breast cancer patients, are concerned about their relationship with pharmaceutical company Genentech following Roche's bid for the company, the A decade-long Nebraska study that showed disparities in breast and cervical cancer screenings could have spurred changes that raised the percentage of women screened in the state. "Disparities in screening between racial and ethnic groups, even in a homogeneous state such as Nebraska, are a problem and by digging into some of the differences we were able to have an impact on breast and cervical cancer screening," said lead study author Shingairai Feresu, Ph.D. Women who survive breast cancer for at least five years after treatment have an 89% chance that they will not have a recurrence of the cancer after 10 years and an 81% chance after 15 years, according to a study published online Tuesday in the Journal of the National Cancer Institute, Research by scientists at the University of Sheffield suggests that the combination of zoledronic acid (a drug used to prevent bone loss) and chemotherapy agent doxorubicin could stop the growth of breast cancer tumours. Dr Alexis Willett, Policy Manager at Breakthrough Breast Cancer, says: "Breakthrough welcomes any research which investigates new uses for existing treatments to help benefit people with breast cancer. An article published in The Lancet Oncology reports that postmenopausal women with breast cancer who are on endocrine treatment are likely to experience arthralgia and arthritis (joint symptoms) if they previously have used hormone replacement therapy (HRT), received a hormone-receptor positive tumor diagnosis, undergone chemotherapy, received treatment with anastrozole versus tamoxifen, or been obese. Scientists in the UK and Finland have discovered that a new combination of the chemotherapy drug doxorubicin and the bone-protecting drug zoledronic acid, both of which are considerably cheaper than herceptin, stopped breast cancer tumors growing in mice. Experts suggest that since both drugs are already in use, and if the combination proves effective and safe in human clinical trials, it should not take as long for it to be available as a new treatment for patients. Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute. Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute. Famous names from the fashion, television, radio and music industries have come together to back Fashion Targets Breast Cancer® (FTBC) UK in an advertising campaign which subtly plays on the topic of celebrity charity endorsement. Natalie Imbruglia, Anna Friel, Alan Carr, Edith Bowman and Twiggy have been shot by acclaimed photographer Rankin wearing their FTBC T-shirts with pride for the campaign from leading charity Breakthrough Breast Cancer which aims to raise £1m. US researchers estimated that the risk of relapse for breast cancer patients who were cancer-free for five years after systemic therapy (chemotherapy, hormone therapy, or both, as well as surgery) was not negligible although it was probably lower than many people realized. Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer. American Airlines, the world's largest airline, and Susan G. Komen for the Cure®, the world's largest breast cancer organization, announced an expanded partnership with the unveiling of two specially co-branded aircraft, an American Airlines Boeing 757 and an American Eagle Embraer 145, each incorporating the renowned vivid pink-ribbon motif. Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer. The primary objective of the Phase I/II, dose escalation study is to determine the safety, maximum tolerated dose (MTD) and objective response rate of GRN163L when administered intravenously in combination with a paclitaxel/bevacizumab regimen in this patient population. A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers. The research, published by Cell Press in the August 7 issue of the American Journal of Human Genetics, is the first in over thirteen years to identify an alternate susceptibility gene for Cowden syndrome (CS) and related disorders. |
|
|
|
Breast Cancer Digest RELATED ARTICLES Early Breast Cancer Detection Most women are familiar with mammography as our "gold standard" for breast cancer screening. However, there are additional tools available that women can add to their arsenal. Victorious There it is again. I muttered to myself, frustrated as I washed my arm. Breast Cancer Statistics - How Breast Cancer Survival Rates Increased 50% Breast cancer statistics show that over 1.2 million persons will be diagnosed with breast cancer worldwide this year, according to the World Health Organization. Emotional Responses to Breast Cancer - Understanding the One You Love Being diagnosed with breast cancer is a life-changing event. A torrent of feelings wash over the survivor. Finding the Spirit - Identifying the Enemy In the daily fight for survival our vision is blurred because our health is compromised. This is when the enemy attacks- we lose focus and become vulnerable. Lets Start Screening For Breast Health In the United States, American women are told to begin annual mammographic screening for breast cancer at the age of 40. Long before we've reached this age, we are advised to perform a monthly breast exam and see our doctors for a clinical breast exam (CBE) annually as well. Your Risk of Cancer Can Increase With Weight Gain! We hear it all the time?lose weight for your health. Few people however, realize the extent to which this is critical to their physical well-being and ultimately their life expectancy. Screening For Breast Cancer With No Compression And No Radiation Who would have thought that a technology for detecting breast cancer used today actually had its' roots dating back to 480 B.C. Naural Self-Defense Against Breast Cancer - Learning to Cope Successfully with Organochlorine Pollut What are organochlorines?Organochlorines are chemicals found in some herbicides and pesticides, in chlorine bleach and most chemical disinfectants, and many plastics, especially PVC (polyvinylchloride).Organochlorines are implicated in causing and promoting breast cancer because they mutate genes and they cause breast cells to become more receptive to a cancer-promoting chemical called estradiol. Antiperspirants And Breast Cancer Most underarm antiperspirants contain as the active ingredient, Aluminium Chlorohydrate, as you will probably remember there has been controversy about Aluminium, since the 1950's when it was a popular metal used for making cooking pots, Saucepans and Fry Pans and that it could be one of the contributing factors to Alzheimer's, now we have another problem that could also be related to Aluminium, Breast Cancer.Research shows that one of the leading causes of Breast Cancer could be the use of antiperspirants. Gift Giving for Breast Cancer Patients and Their Families Did you know that each year, 182,000 women are diagnosed with breast cancer and 43,300 die? One woman in eight either has or will develop breast cancer in her lifetime. In addition, 1,600 men will be diagnosed with breast cancer and 400 will die this year. Breast Cancer The Cure You have my permission to publish this article electronically or in print, free of charge, as long as the bylines are included. A courtesy copy of your publication would be appreciated. Breast Cancer Awareness and Prevention Tips October is Breast Cancer Awareness month. Men and women can take preventative steps for avoiding breast cancer and staying healthy. The News You Dont Want To Hear: Youve Got Breast Cancer For many people being told that they have cancer is one of the most stressful times in their lives. Just as we think we have everything under control, something comes along that can shatter even the strongest of wills. New Advances In Early Breast Cancer Detection In November 2003, the American Cancer Society stated that breast cancer is the leading cause of death in women between the ages of 40 and 44. In the United States, there are approximately 200,000 new cases of breast cancer and more than 40,000 deaths; making the U. Fourteen Simple Things You Can Do To Reduce Your Risk for Breast Cancer 1. Increase your consumption of fresh, organic fruits and vegetables. Breast Cancer - 101 The cancer is a term for diseases in which abnormal cells divide uncontrollably invading near by tissue and spreading to other parts of the body via blood stream or lymphatic system.Similarly, in breast cancer, a single cell begins to divide and grow abnormally. Breast Cancer In December of 2001, breast cancer was the furthest thing from my mind. I was busy. Are Obese Women Getting Short-Changed By Chemotherapy Treatments? How much chemotherapy does an obese woman need? Typically an obese woman with breast cancer would receive reduced doses of chemotherapy as they battle breast cancer.Back in June of 2005, a study published in the Archives of Internal Medicine concluded that obese women should receive chemotherapy based on their actual weight, and not in reduced as amounts as it the standard practice. Breast Cancer Detection Unit for the Home Detecting Breast Cancer early is a key step in protecting yourself from the dire consequences and risk of breast cancer. There is now some new technology using Infrared to help you do self-examinations in the privacy of your own home.
|
| home | site map| privacy policy |
| © 2008, Celerity Consultants, Mumbai, India, All Rights Reserved |